Novartis AG (NVS)
NYSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 11.96B | 13.97B | 12.95B | 14.19B | 6.87B | 20.09B | 11.83B | 13.16B |
| Operating Income | 2.16B | 1.95B | 2.86B | 2.92B | 1.41B | 2.84B | 3.34B | 4.01B |
| Pre Tax Income | 1.92B | 1.74B | 2.74B | 2.77B | 1.24B | 2.59B | 3.13B | 3.84B |
| Net Income | 1.57B | 1.47B | 2.29B | 2.32B | 1.76B | 8.48B | 2.69B | 3.25B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 2.16B | 1.95B | 2.86B | 2.92B | 1.41B | 2.84B | 3.34B | 4.01B |
| EBITDA | 4.19B | 3.9B | 4.85B | 2.75B | 6.27B | 4.44B | 4.66B | 5.17B |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 49.44B | 50.14B | 53.17B | 50.49B | 49.9B | 52.88B | 51.83B | 54.11B |
| Operating Income | 8.97B | 9.74B | 14.61B | 9.82B | 10.83B | 27.03B | 9.19B | 10.02B |
| Pre Tax Income | 7.82B | 9B | 13.84B | 9B | 9.88B | 26.14B | 8.37B | 9.33B |
| Net Income | 6.71B | 7.7B | 12.61B | 11.73B | 8.07B | 24.02B | 6.96B | 14.85B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 2.753 | 3.234 | 5.309 | 5.037 | 3.478 | 10.449 | 3.185 | 7.046 |
| EBIT | 8.98B | 9.75B | 14.61B | 9.82B | 10.83B | 27.03B | 9.19B | 10.02B |
| EBITDA | 15.03B | 15.85B | 21.34B | 15.68B | 17.3B | 33.24B | 16.38B | 18.31B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
